Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(17 sites)
United States
University of Alabama Birmingham, Birmingham, Alabama City of Hope, Duarte, California Cedars Sinai, Los Angeles, California Scripps Health, San Diego, California University of Miami, Miami, Florida